Home » Knowledge Center » Mechanism of BRAF Inhibitor Resistance Revealed by Cell Panel Screening and Bioinformatics
Mechanism of BRAF Inhibitor Resistance Revealed by Cell Panel Screening and Bioinformatics
This research aims to elucidate the underlying mechanisms responsible for the variable efficacy of Dabrafenib, a potent inhibitor of the BRAF V600E mutation, across diverse cancer type.